Indian Journal of Medical Research

REVIEW ARTICLE
Year
: 2015  |  Volume : 141  |  Issue : 2  |  Page : 172--174

Current advances related to Clostridium difficile infection


Yong Gil Kim1, Byung Ik Jang2 
1 Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, South Korea
2 Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea

Correspondence Address:
Dr. Byung Ik Jang
Department of Internal Medicine, Yeungnam University College of Medicine, Daegu
South Korea

Clostridium difficile infection (CDI) can trigger various responses, ranging from asymptomatic carriage to fulminant colitis. Hard-to-cure CDI, such as severe CDI, multiple recurrences of CDI, refractory CDI, and hypervirulent strains of C. difficile, require new treatments, although antibiotics such as metronidazole and vancomycin are the treatment of choice for initial and first relapsing CDI. Active immunization with C. difficile toxins and faecal microbiota transplantation deserve special attention. Here we describe these strategies for difficult-to-treat CDI.


How to cite this article:
Kim YG, Jang BI. Current advances related to Clostridium difficile infection.Indian J Med Res 2015;141:172-174


How to cite this URL:
Kim YG, Jang BI. Current advances related to Clostridium difficile infection. Indian J Med Res [serial online] 2015 [cited 2019 Aug 20 ];141:172-174
Available from: http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2015;volume=141;issue=2;spage=172;epage=174;aulast=Kim;type=0